920-CGS-200
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 920-CGS-200, covering 2020-03-30 to 2020-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Osteoarthritis Knee Pain Relief Study of 0.25% 920-CGS-200 [Phase 4]